AEON Biopharma, Inc.'s latest marketcap:
As of 07/26/2025, AEON Biopharma, Inc.'s market capitalization has reached $8.65 M. According to our data, AEON Biopharma, Inc. is the 41488th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | $8.65 M |
| Revenue (ttm) | $0 |
| Net Income (ttm) | $169.12 M |
| Shares Out | 11.31 M |
| EPS (ttm) | $117.22 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/11/2025 |
AEON Biopharma, Inc.'s yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/26/2025 | $8.65 M | -57.47% | 41488 |
| 12/31/2024 | $21.58 M | -91.93% | n/a |
| 12/29/2023 | $267.55 M | -80.82% | n/a |
| 12/30/2022 | $1.4 B | 553.24% | n/a |
| 12/30/2021 | $213.58 M | n/a |
Company Profile
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins.
It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder.
The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Frequently Asked Questions
-
What is AEON Biopharma, Inc.'s (AEON) current market cap?As of 07/26/2025, AEON Biopharma, Inc. (including the parent company, if applicable) has an estimated market capitalization of $8.65 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does AEON Biopharma, Inc. (AEON) rank globally by market cap?AEON Biopharma, Inc. global market capitalization ranking is approximately 41488 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.